Albuterol metered aerosol is a generic inhaler that’s prescribed for certain types of bronchospasm. It’s not known whether albuterol metered aerosol is safe to use during pregnancy and breastfeeding.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

RIDGEFIELD, Conn., Oct. 7, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, ...

PRINCETON, N.J., March 16, 2021 /PRNewswire/ -- Sandoz Inc. today announced the in-licensing of commercial distribution rights to the brand and authorized generic of respiratory inhalation medicine ...

On July 6, 2023, Cipla US recalled six batches of its albuterol sulfate inhalation aerosol, 90 mcg (200 MI). According to the release published by the FDA on July 7, 2023, the company cited a ...

MUMBAI, India, April 9, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ); (and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Albuterol 90mcg/inh; metered-dose aerosol. <4yrs: not recommended. ≥4yrs: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise–induced bronchospasm: 2 inh 15 minutes before exercise.

About one out of 12 people in the United States has asthma. Asthma is a chronic (long-term) lung condition in which airways can become inflamed and narrowed. This makes it difficult to get air in and ...

Lupin jumped 6.75% to Rs 1108. The stock rose as much as 7.39% at the day's high at Rs 1114.65 today, which is also 52-week high for the counter. Cipla surged 5.84% to Rs 796. The scrip jumped as much ...

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...